These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1179128)

  • 1. [Coronary insufficiency in patients with gout].
    May V; Robert H
    Rev Rhum Mal Osteoartic; 1975; 42(7-9):471-4. PubMed ID: 1179128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence of hyperuricemia and gout in coronary insufficiency from angina pectoris to myocardial infarct].
    May V; Robert H
    Rev Rhum Mal Osteoartic; 1975; 42(7-9):467-70. PubMed ID: 1179127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interrelationships between the hemostatic system and the prostaglandin system in the pathogenesis of ischemic cardiopathy].
    Neri Serneri GG; Masotti G; Gensini GF; Abbate R; Poggesi L
    G Ital Cardiol; 1981; 11(10):1500-13. PubMed ID: 7042438
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet abnormalities in ischemic heart disease.
    Salky N; Dugdale M
    Am J Cardiol; 1973 Oct; 32(5):612-7. PubMed ID: 4744691
    [No Abstract]   [Full Text] [Related]  

  • 5. Medically unattended fatal cases of ischaemic heart disease in a defined population.
    Wikland B
    Acta Med Scand Suppl; 1971; 524():3-78. PubMed ID: 5292805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gout: current views. Stage oriented treatment].
    Fedorova NE; Grigor'eva VD
    Klin Med (Mosk); 2002; 80(2):9-13. PubMed ID: 11898731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The "natural" history of ischemic cardiopathy, Incidence of coronary events in the follow-up of 114 ambulatory patients].
    Puletti M; Staropoli P; Molaioni C; Matteoli S; Trappolini M; Curione M
    Minerva Cardioangiol; 1995; 43(1-2):1-6. PubMed ID: 7792013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myocardial infarction in hyperthyroidism (author's transl)].
    Ortega Carnicer J; Font de Mora A; Aguado Borruey JM; García Ruiz F; Delgado Lacosta M
    Med Clin (Barc); 1981 May; 76(9):408-11. PubMed ID: 7242171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Change in the coagulation and anticoagulation systems of the blood in patients with coronary cardiosclerosis with symptoms of stenocardia in treatment with heparin electrophoresis].
    Glagoleva NA; Shubina AV
    Ter Arkh; 1967 Sep; 39(9):88-93. PubMed ID: 5611710
    [No Abstract]   [Full Text] [Related]  

  • 10. Anatomoclinical correlations in coronary heart disease: recent advances and unanswered questions.
    Velican D; Iacob M
    Med Interne; 1989; 27(1):3-14. PubMed ID: 2665043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Elements of risk of ischemic heart disease in patients with primary gout and its behavior as a function of the basic treatment].
    Weryńska-Przybylska J; Brzozowska-Jurkowska AM; Eyman E; Frackiewicz A; Mikołajew M; Pilichowska I; Stachurska J; Szymańska M; Kawenoki-Minc E
    Reumatologia; 1981; 19(3-4):277-86. PubMed ID: 7347876
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationship between metabolic diseases and the severity of coronary disease].
    Berg G; Bachmann K; Matzkies F; Bergner D; Grabner W; Bornhofen E; Stürzenhofecker P; Sailer D
    Arzneimittelforschung; 1972 Oct; 22(10):1806-8. PubMed ID: 4678568
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of coronary artery spasm in ischemic heart disease. Therapeutic implications.
    Conti CR
    G Ital Cardiol; 1984 Nov; 14(11):901-10. PubMed ID: 6335445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
    Panchenko EP; Shalaev SV; Men'shikov MIu; Tkachuk VA; Gratsianskiĭ NA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):90-6. PubMed ID: 3801147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis/platelets and other blood factors in acute coronary syndromes.
    Stein B; Badimon L; Israel DH; Badimon JJ; Fuster V
    Cardiovasc Clin; 1989; 20(1):105-29. PubMed ID: 2653627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Statistics for the study of cerebrovascular insufficiency due to occlusive or stenotic lesions of the carotid artery. I].
    Tedeschi G; Signorelli CD; De Divitiis E
    Rass Int Clin Ter; 1971 May; 51(9):534-42. PubMed ID: 5088698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-statistical studies on coronary insufficiency and heart rhythm changes in an aged patient with gout].
    Varricchio M; Tirri G; Russo R; Gentile S
    G Gerontol; 1971 Apr; 19(4):261-72. PubMed ID: 5143155
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the production of anti-heart autoantibodies in coronary insufficiency].
    Terekhova NA
    Klin Med (Mosk); 1969 Jan; 47(1):118-22. PubMed ID: 5771267
    [No Abstract]   [Full Text] [Related]  

  • 19. [Calcium metabolism of the thrombocytes in ischemic heart disease].
    Kiktev VG; Men'shikov MIu; Bugriĭ EM; Kuz'min AV; Karpov IuA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(2):58-61. PubMed ID: 3233156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
    Czyz A; Kołacz E; Angerer D; Zawilska K
    Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.